Journal Mobile Options
Table of Contents
Vol. 163, No. 4, 2014
Issue release date: May 2014
Int Arch Allergy Immunol 2014;163:313-318
(DOI:10.1159/000360734)

A Nasally Applied Cellulose Powder in Seasonal Allergic Rhinitis in Adults with Grass Pollen Allergy: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study

Åberg N. · Ospanova S.T. · Nikitin N.P. · Emberlin J. · Dahl Å.
Departments of aPediatrics and bBiological and Environmental Sciences, University of Gothenburg, Gothenburg, Sweden; cDepartment of Internal Medicine, National Medical University, Kharkov, Ukraine; dRUSSLAN Clinical Research, Douglas, Isle of Man; eAllergy UK, Sidcup, UK

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: A nasally applied cellulose powder is increasingly used in many countries as a remedy for allergic rhinitis. In 2009, a 4-week study in birch pollen-allergic children showed a reduction in nasal symptoms. The best effect occurred on days with lower pollen counts. The present study in grass pollen-allergic adults used the same basic design. Methods: In May 2013, a double-blind, placebo-controlled study was conducted in 108 patients with allergic rhinitis due to grass pollen (18-40 years of age). SMS on mobile phones were used as reminders of treatment and reporting of symptom scores. Results: We found significant reductions in severity scores for sneezing, runny nose, stuffy nose and symptoms from eyes and lower airways, both separately and together (all p < 0.001). Reflective opinion of effect and guess on treatment at follow-up visits (both p < 0.001) confirmed a high efficacy. No clinically significant adverse effects were reported. Conclusions: The product provided significant protection against all seasonal allergic rhinitis symptoms from both upper and lower airways during the grass pollen season in an adult population. The magnitude and scope of efficacy support the use of the product as an early choice in the treatment of allergic rhinitis. © 2014 S. Karger AG, Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Nathan RA, Meltzer EO, Derebery J, et al: The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 2008;29:600-608.
  2. Aberg N, Engström I: Natural history of allergic diseases in children. Acta Paediatr Scand 1990;79:206-211.
  3. Hesselmar B, Aberg B, Eriksson, Aberg N: Allergic rhinoconjunctivitis, eczema, and sensitization in two areas with differing climates. Pediatr Allergy Immunol 2001;12:208-215.
  4. Sundberg R, Torén K, Höglund D, Aberg N, Brisman J: Nasal symptoms are associated with school performance in adolescents. J Adolesc Health 2007;40:581-583.
  5. Valovirta E, Myrseth SE, Palkonen S: The voice of the patients: allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin Immunol 2008;8:1-9.
  6. Diethart B: The Use of Inert Hydroxypropylmethylocellulose Powder as a Remedy for Allergic Rhinitis; PhD thesis, University of Coventry/University of Worcester, 2009.
  7. Aberg N, Dahl A, Benson M: A nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load. Pediatr Allergy Immunol 2011;22:594-599.
  8. Burr ML, Emberlin JE, Treuw R, Chengz S, Pearcez NE; ISAAC Phase One Study Group: Pollen counts in relation to the prevalence of allergic rhinoconjunctivitis, asthma and atopic eczema in the International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy 2003;33:1675-1680.
  9. Emberlin JC, Lewis RA: A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin 2006;22:275-285.
  10. Emberlin JC, Lewis RA: A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1. Curr Med Res Opin 2007;23:2423-2431.
  11. Lauritsen K, Degl' Innocenti A, Hendel L, Praest J, Lytje MF, Clemmensen-Rotne K, Wiklund I: Symptom recording in a randomised clinical trial: paper diaries versus electronic or telephone data capture. Control Clin Trials 2004;25:585-597.
  12. Braunstahl GJ: United airways concept: what does it teach us about systemic inflammation in airways disease? Proc Am Thorac Soc 2009;6:652-654.
  13. Lightman S, Scadding GK: Should intranasal corticosteroids be used for the treatment of ocular symptoms of allergic rhinoconjunctivitis? A review of their efficacy and safety profile. Int Arch Allergy Immunol 2012;158:317-325.
  14. de Weger LA, Beerthuizen T, Gast-Strookman JM, van der Plas DT, Terreehorst I, Hiemstra PS, Sont JK: Difference in symptom severity between early and late grass pollen season in patients with seasonal allergic rhinitis. Clin Transl Allergy 2011;1:18.

    External Resources

  15. Kiotseridis H, Cilio CM, Bjermer L, Tunsäter A, Jacobsson H, Dahl Å: Grass pollen allergy in children and adolescents - symptoms, health related quality of life and the value of pollen prognosis. Clin Transl Allergy 2013;3:19.

    External Resources

  16. Brożek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-476.
  17. Parle-Pechera S, Powers L, St Anna L: Clinical inquiries. Intranasal steroids vs antihistamines: which is better for seasonal allergies and conjunctivitis? J Fam Pract 2012;61:429-431.
  18. Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE: Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Arch Allergy Immunol 2011;156:1-15.
  19. Hamelmann E, Beyer K, Gruber C, Lau S, Matricardi PM, Nickel R, Niggemann B, Wahn U: Primary prevention of allergy: avoiding risk or providing protection? Clin Exp Allergy 2008;38:233-245.
  20. Hermelingmeier KE, Weber RK, Hellmich M, Heubach CP, Mösges R: Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy 2012;26:119-125.

    External Resources

  21. Cingi C, Unlu HH, Songu M, Yalcin S, Topcu I, Cakli H, Bal C: Seawater gel in allergic rhinitis: entrapment effect and mucociliary clearance compared with saline. Ther Adv Respir Dis 2010;4:13-18.
  22. Andersson M, Greiff L, Wollmer P: Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis. Acta Otolaryngol 2008;128:666-669.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50